Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.6160
+0.0160 (2.67%)
At close: Jul 20, 2026, 4:00 PM EDT
0.6150
-0.0010 (-0.16%)
Pre-market: Jul 21, 2026, 4:00 AM EDT
Context Therapeutics Employees
Context Therapeutics had 15 employees as of December 31, 2025. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$2,681,795
Market Cap
56.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 3 | 25.00% |
| Dec 31, 2024 | 12 | 7 | 140.00% |
| Dec 31, 2023 | 5 | -4 | -44.44% |
| Dec 31, 2022 | 9 | - | - |
| Jun 30, 2021 | 2 | - | - |
| Mar 31, 2021 | 2 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 76 |
| Seres Therapeutics | 66 |
| BeyondSpring | 44 |
| Elicio Therapeutics | 33 |
| eXoZymes | 32 |
| Boundless Bio | 28 |
| Filana Therapeutics | 20 |
| Edesa Biotech | 17 |
CNTX News
- 10 days ago - Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 14 days ago - Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 4 weeks ago - Context Therapeutics price target lowered to $4 from $8 at Maxim - TheFly
- 5 weeks ago - Context Therapeutics selloff brings buying opportunity, says JonesResearch - TheFly
- 5 weeks ago - Context stock reaction ‘overdone’ after CTIM-76 data, says H.C. Wainwright - TheFly
- 5 weeks ago - Context Therapeutics Transcript: Study result - Transcripts
- 5 weeks ago - Context Therapeutics Press release: Study result - Filings
- 5 weeks ago - Context Therapeutics Slides: Study result - Filings